BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Ansaldi F, Orsi A, Sticchi L, Bruzzone B, Icardi G. Hepatitis C virus in the new era: Perspectives in epidemiology, prevention, diagnostics and predictors of response to therapy. World J Gastroenterol 2014; 20(29): 9633-9652 [PMID: 25110404 DOI: 10.3748/wjg.v20.i29.9633]
URL: https://www.wjgnet.com/1948-5182/full/v20/i29/9633.htm
Number Citing Articles
1
M. J. Nielsen, M. A. Karsdal, K. Kazankov, H. Grønbaek, A. Krag, D. J. Leeming, D. Schuppan, J. George. Fibrosis is not just fibrosis - basement membrane modelling and collagen metabolism differs between hepatitis B- and C-induced injuryAlimentary Pharmacology & Therapeutics 2016; 44(11-12): 1242 doi: 10.1111/apt.13819
2
Simona Georgescu, Mircea Tampa, Madalina Mitran, Cristina Mitran, Maria Sarbu, Ilinca Nicolae, Clara Matei, Constantin Caruntu, Monica Neagu, Mircea Popa. Potential pathogenic mechanisms involved in the association between lichen planus and hepatitis C virus infection (Review)Experimental and Therapeutic Medicine 2018;  doi: 10.3892/etm.2018.6987
3
Cecilia Trucchi, Andrea Orsi, Cristiano Alicino, Laura Sticchi, Giancarlo Icardi, Filippo Ansaldi. State of the Art, Unresolved Issues, and Future Research Directions in the Fight against Hepatitis C Virus: Perspectives for Screening, Diagnostics of Resistances, and ImmunizationJournal of Immunology Research 2016; 2016: 1 doi: 10.1155/2016/1412840
4
Mohamed AbdElrahman, Marwa K. Ibrahim, Salwa Tawfik, Dalia Omran, Mahmoud M. Bendary, Soha Osama Hassanin, Hassan Elbatae. The relation between SNPs in the NME1 gene and response to sofosbuvir in Egyptian patients with chronic HCVBeni-Suef University Journal of Basic and Applied Sciences 2023; 12(1) doi: 10.1186/s43088-022-00337-6
5
Syed‐Mohammed Jafri, Stuart C. Gordon. Epidemiology of Hepatitis CClinical Liver Disease 2018; 12(5): 140 doi: 10.1002/cld.783
6
Fiona McPhee, Yoshiyuki Suzuki, Joji Toyota, Yoshiyasu Karino, Kasuaki Chayama, Yoshiiku Kawakami, Min Lung Yu, Sang Hoon Ahn, Hiroki Ishikawa, Rafia Bhore, Nannan Zhou, Dennis Hernandez, Patricia Mendez, Hiromitsu Kumada. High Sustained Virologic Response to Daclatasvir Plus Asunaprevir in Elderly and Cirrhotic Patients with Hepatitis C Virus Genotype 1b Without Baseline NS5A PolymorphismsAdvances in Therapy 2015; 32(7): 637 doi: 10.1007/s12325-015-0221-5
7
Giovanni Faria SILVA, Vanessa Gutierrez de ANDRADE, Alecsandro MOREIRA. WAITING DAAS LIST MORTALITY IMPACT IN HCV CIRRHOTIC PATIENTSArquivos de Gastroenterologia 2018; 55(4): 343 doi: 10.1590/s0004-2803.201800000-76
8
Charlie Bernier, Coralie Goetz, Eric Jubinville, Julie Jean. The New Face of Berries: A Review of Their Antiviral ProprietiesFoods 2021; 11(1): 102 doi: 10.3390/foods11010102
9
Anna Davydova, Maria Vorobjeva, Dmitrii Pyshnyi, Sidney Altman, Valentin Vlassov, Alya Venyaminova. Aptamers against pathogenic microorganismsCritical Reviews in Microbiology 2016; 42(6): 847 doi: 10.3109/1040841X.2015.1070115
10
Xhevat Jakupi, Jana Mlakar, Maja M. Lunar, Katja Seme, Ibrahim Rudhani, Lul Raka, Adriana Vince, Mario Poljak. A very high prevalence of hepatitis C virus infection among patients undergoing hemodialysis in Kosovo: a nationwide studyBMC Nephrology 2018; 19(1) doi: 10.1186/s12882-018-1100-5
11
Fumitaka Suzuki, Naoya Hatanaka, Etsuya Bando, Koji Nakamura, Akira Komoto. Safety and effectiveness of daclatasvir and asunaprevir dual therapy in patients with genotype 1 chronic hepatitis C: results from postmarketing surveillance in JapanHepatology International 2018; 12(3): 244 doi: 10.1007/s12072-018-9872-z
12
Tijana Radonjić, Marija Dukić, Igor Jovanović, Marija Zdravković, Olga Mandić, Višeslav Popadić, Maja Popović, Novica Nikolić, Slobodan Klašnja, Anica Divac, Zoran Todorović, Marija Branković. Aging of Liver in Its Different DiseasesInternational Journal of Molecular Sciences 2022; 23(21): 13085 doi: 10.3390/ijms232113085
13
Suhail H Al-Amad. Willingness of dentists in the United Arab Emirates to perform restorative and surgical treatments for patients infected with hepatitis CArchives of Public Health 2021; 79(1) doi: 10.1186/s13690-021-00756-4
14
Marian-Sorin Popescu, Andrei Ioan Drocas, Andrei Osman, Dan-Mihai Firu, Vlad Pădureanu, Cristina Maria Mărginean, Daniel-Cristian Pîrvu, Radu Mitruț, Dragoș Nicolae Mărgăritescu, Antonia Radu, Daniela Calina, Anca Oana Docea, Paul Mitruț. The Extent of Insulin Resistance in Patients That Cleared Viral Hepatitis C Infection and the Role of Pre-Existent Type 2 Diabetes Mellitus: A Meta-AnalysisReports 2022; 5(4): 42 doi: 10.3390/reports5040042
15
Linh Thuy Nguyen, Emma Gray, Jonathan Dean, Michael Carr, Jeff Connell, Cillian De Gascun, Lan Anh Nguyen, Aisling O'Leary, Colm Bergin, William Hall, Suzanne Norris. Baseline Prevalence and Emergence of Protease Inhibitor Resistance Mutations following Treatment in Chronic HCV Genotype-1-Infected IndividualsAntiviral Therapy 2015; 20(8): 865 doi: 10.3851/IMP2964
16
Kerstin Wissel, Pietro Vernazza, Stefan Kuster, Katharina Hensel-Koch, Andrea Bregenzer. Hepatitis C prevalence and cascade of care among patients in the decentralised opioid agonist therapy programme of the canton of St Gallen, Switzerland: a cross-sectional studySwiss Medical Weekly 2024; 154(2): 3352 doi: 10.57187/s.3352
17
Helen Hampton, ElizabethS Farrington, Adam Ellery, Mary McKenna, William Stableforth, Hyder Hussaini. Community hepatitis C treatment in Cornwall: a model to improve careGastrointestinal Nursing 2015; 13(Sup5): S17 doi: 10.12968/gasn.2015.13.Sup5.S17
18
Zobair M. Younossi, Maria Stepanova, Nezam Afdhal, Kris V. Kowdley, Stefan Zeuzem, Linda Henry, Sharon L. Hunt, Patrick Marcellin. Improvement of health-related quality of life and work productivity in chronic hepatitis C patients with early and advanced fibrosis treated with ledipasvir and sofosbuvirJournal of Hepatology 2015; 63(2): 337 doi: 10.1016/j.jhep.2015.03.014
19
Anika Jabin, Mohammad Fahim Uddin, Salauddin Al Azad, Ashfaque Rahman, Fawzia Tabassum, Pritthy Sarker, A K M Helal Morshed, Samiur Rahman, Fatima Fairuz Raisa, Musfiqur Rahman Sakib, Abeer Hasan Olive, Tabassum Islam, Ramisha Tahsin, Shahlaa Zernaz Ahmed, Partha Biswas, Mst. Umme Habiba, Mahbuba Siddiquy, Maryam Jafary. Target-specificity of different amyrin subunits in impeding HCV influx mechanism inside the human cells considering the quantum tunnel profiles and molecular strings of the CD81 receptor: a combined in silico and in vivo studyIn Silico Pharmacology 2023; 11(1) doi: 10.1007/s40203-023-00144-6
20
Renee Pozza, Catherine Hill, Anna Marie Hefner, Beth Vawter, Tarek Hassanein. Hepatitis C infectionThe Nurse Practitioner 2017; 42(5): 14 doi: 10.1097/01.NPR.0000515423.38284.28
21
Riccardo Scotto, Antonio Riccardo Buonomo, Nicola Schiano Moriello, Alberto Enrico Maraolo, Emanuela Zappulo, Biagio Pinchera, Ivan Gentile, Guglielmo Borgia. Real-World Efficacy and Safety of Pangenotypic Direct-Acting Antivirals Against Hepatitis C Virus InfectionReviews on Recent Clinical Trials 2019; 14(3): 173 doi: 10.2174/1574887114666190306154650
22
Sylwia Osuch, Karin J. Metzner, Kamila Caraballo Cortés. Reversal of T Cell Exhaustion in Chronic HCV InfectionViruses 2020; 12(8): 799 doi: 10.3390/v12080799
23
Michelle Pardee. Diagnosis and Management of Hepatitis B and CNursing Clinics of North America 2019; 54(2): 277 doi: 10.1016/j.cnur.2019.02.004
24
Antoni Sicras-Mainar, Ruth Navarro-Artieda, Marc Sáez-Zafra. Comorbilidad, medicación concomitante, uso de recursos y costes sanitarios asociados a los pacientes portadores del virus de la hepatitis C crónica en EspañaGastroenterología y Hepatología 2018; 41(4): 234 doi: 10.1016/j.gastrohep.2017.11.008
25
Johnathan D. Guest, Ruixue Wang, Khadija H. Elkholy, Andrezza Chagas, Kinlin L. Chao, Thomas E. Cleveland, Young Chang Kim, Zhen-Yong Keck, Alexander Marin, Abdul S. Yunus, Roy A. Mariuzza, Alexander K. Andrianov, Eric A. Toth, Steven K. H. Foung, Brian G. Pierce, Thomas R. Fuerst. Design of a native-like secreted form of the hepatitis C virus E1E2 heterodimerProceedings of the National Academy of Sciences 2021; 118(3) doi: 10.1073/pnas.2015149118
26
Waqar Al-Kubaisy, Suzanna Daud, Mustafa Waseem Al-Kubaisi, Omar Waseem Al-Kubaisi, Nik Nairan Abdullah. Maternal hepatitis C (HCV) infection and Anti-D immunoglobulin therapy: study testing antibodies, RNA and Genotype of HCV in BaghdadThe Journal of Maternal-Fetal & Neonatal Medicine 2019; 32(20): 3464 doi: 10.1080/14767058.2018.1465557
27
Arthi Venkatesan, Febin Prabhu Dass J.. Review on chemogenomic approaches towards hepatitis C viral targetsJournal of Cellular Biochemistry 2019; 120(8): 12167 doi: 10.1002/jcb.28581
28
Shereen Abou Bakr Saleh, Khaled Mohamed Abdelwahab, Asmaa Mady Mady, Ghada Abdelrahman Mohamed. The impact of achieving a sustained virological response with direct-acting antivirals on serum autotaxin levels in chronic hepatitis C patientsEgyptian Liver Journal 2020; 10(1) doi: 10.1186/s43066-020-00060-w
29
Miguel Angel Martinez, Sandra Franco. Therapy Implications of Hepatitis C Virus Genetic DiversityViruses 2020; 13(1): 41 doi: 10.3390/v13010041
30
Lenche Kostadinova, Carey L. Shive, Chelsey Judge, Elizabeth Zebrowski, Anita Compan, Kelsey Rife, Amy Hirsch, Yngve Falck-Ytter, Daniela M. Schlatzer, Xiaolin Li, Mark R. Chance, Benigno Rodriguez, Daniel L Popkin, Donald D. Anthony. During Hepatitis C Virus (HCV) Infection and HCV-HIV Coinfection, an Elevated Plasma Level of Autotaxin Is Associated With Lysophosphatidic Acid and Markers of Immune Activation That Normalize During Interferon-Free HCV TherapyJournal of Infectious Diseases 2016; 214(9): 1438 doi: 10.1093/infdis/jiw372
31
Allison E. Wang, Eric Hsieh, Barbara J. Turner, Norah Terrault. Integrating Management of Hepatitis C Infection into Primary Care: the Key to Hepatitis C Elimination EffortsJournal of General Internal Medicine 2022; 37(13): 3435 doi: 10.1007/s11606-022-07628-9
32
Miguel Angel Martinez, Sandra Franco. Antiviral Drug Discovery and DevelopmentAdvances in Experimental Medicine and Biology 2021; 1322: 139 doi: 10.1007/978-981-16-0267-2_6
33
Germana Grassi, Giorgia Di Caprio, Gian Maria Fimia, Giuseppe Ippolito, Marco Tripodi, Tonino Alonzi. Hepatitis C virus relies on lipoproteins for its life cycleWorld Journal of Gastroenterology 2016; 22(6): 1953-1965 doi: 10.3748/wjg.v22.i6.1953
34
Lenche Kostadinova, Carey L Shive, Donald D Anthony. Elevated Autotaxin and LPA Levels during Chronic Viral Hepatitis and Hepatocellular Carcinoma Associate with Systemic Immune ActivationCancers 2019; 11(12): 1867 doi: 10.3390/cancers11121867
35
Antoni Sicras-Mainar, Ruth Navarro-Artieda, Marc Sáez-Zafra. Comorbidity, concomitant medication, use of resources and healthcare costs associated with chronic hepatitis C virus carriers in SpainGastroenterología y Hepatología (English Edition) 2018; 41(4): 234 doi: 10.1016/j.gastre.2018.04.015
36
Ping Chen, Yang Zheng, Yubo Cai, Pengfei Zou, Nan Li, Conggao Peng, Hainv Gao, Jimin Liu, Yongping Chen, Zhaowei Tong, Lanjuan Li. Prevalence of Hepatitis C Virus Infection in a Surgical Population of Southeast China: A Large-Scale Multicenter StudyCanadian Journal of Gastroenterology and Hepatology 2020; 2020: 1 doi: 10.1155/2020/8219536
37
Irini D. Batsis, Paul Wasuwanich, Wikrom W. Karnsakul. The management of hepatitis B and hepatitis C in childrenMinerva Pediatrica 2018; 71(1) doi: 10.23736/S0026-4946.18.05410-5
38
Francesco Lapi, Alice Capogrosso Sansone, Stefania Mantarro, Monica Simonetti, Marco Tuccori, Corrado Blandizzi, Alessandro Rossi, Giampaolo Corti, Alessandro Bartoloni, Alfonso Bellia, Leonardo Baiocchi, Iacopo Cricelli, Claudio Cricelli. Hepatitis C virus infection: opportunities for an earlier detection in primary careEuropean Journal of Gastroenterology & Hepatology 2017; 29(3): 271 doi: 10.1097/MEG.0000000000000785
39
Naomi Lange, Jean-François Dufour. Changing Epidemiology of HCC: How to Screen and Identify Patients at Risk?Digestive Diseases and Sciences 2019; 64(4): 903 doi: 10.1007/s10620-019-05515-8
40
Alexander M. Sy, Christopher B. O’Brien. Liver Failure2020; : 167 doi: 10.1007/978-3-030-50983-5_9
41
Anna Karin Belfrage, Eldar Abdurakhmanov, Eva Åkerblom, Peter Brandt, Hiba Alogheli, Johan Neyts, U. Helena Danielson, Anja Sandström. Pan-NS3 protease inhibitors of hepatitis C virus based on an R3-elongated pyrazinone scaffoldEuropean Journal of Medicinal Chemistry 2018; 148: 453 doi: 10.1016/j.ejmech.2018.02.032
42
Graham R. Foster, Kazuaki Chayama, Wan-Long Chuang, Hugo Fainboim, Martti Farkkila, Adrian Gadano, Giovanni B. Gaeta, Christophe Hézode, Yukiko Inada, Jeong Heo, Hiromitsu Kumada, Sheng-Nan Lu, Patrick Marcellin, Christophe Moreno, Stuart K. Roberts, Simone I. Strasser, Alexander J. Thompson, Joji Toyota, Seung Woon Paik, John M. Vierling, Anna L. Zignego, David Cohen, Fiona McPhee, Megan Wind-Rotolo, Subasree Srinivasan, Matthew Hruska, Heather Myler, Simon D. Portsmouth. A randomized, controlled study of peginterferon lambda-1a/ribavirin ± daclatasvir for hepatitis C virus genotype 2 or 3SpringerPlus 2016; 5(1) doi: 10.1186/s40064-016-2920-z
43
Ying Wang, Bairong Shen. Translational InformaticsAdvances in Experimental Medicine and Biology 2022; 1368: 21 doi: 10.1007/978-981-16-8969-7_2
44
Bart Fevery, Simone Susser, Oliver Lenz, Gavin Cloherty, Dany Perner, Leen Gilles, Patrick De Locht, Gaston Picchio, Sandra De Meyer, Christoph Sarrazin. Comparison of three quantitative HCV RNA assays in samples from HCV genotype 1- or 4-infected patients treated with the NS3/4A protease inhibitor simeprevirJournal of Clinical Virology 2015; 72: 133 doi: 10.1016/j.jcv.2015.09.015
45
Sofija Sekulic, Zeljko Mijailovic, Dejan Petrovic, Ruzica Lukic, Marina Jovanovic, Ivan Jovanovic. HCV Infection and Chronic Renal DiseaseSerbian Journal of Experimental and Clinical Research 2021; 0(0) doi: 10.2478/sjecr-2021-0010
46
Melanie Mallory, David Hillyard. Clinical Virology Manual2016; : 351 doi: 10.1128/9781555819156.ch25
47
Hsu-Heng Yen, Pei-Yuan Su, Ya-Huei Zeng, I-Ling Liu, Siou-Ping Huang, Yu-Chun Hsu, Yang-Yuan Chen, Chia-Wei Yang, Shun-Sheng Wu, Kun-Ching Chou, Tatsuo Kanda. Glecaprevir–pibrentasvir for chronic hepatitis C: Comparing treatment effect in patients with and without end-stage renal disease in a real-world settingPLOS ONE 2020; 15(8): e0237582 doi: 10.1371/journal.pone.0237582
48
Mansun Law. Antibody Responses in Hepatitis C InfectionCold Spring Harbor Perspectives in Medicine 2021; 11(3): a036962 doi: 10.1101/cshperspect.a036962
49
Tse-Ling Fong, Brian T. Lee, Mimi Chang, Khishigsuren Nasanbayar, Enkhjargal Tsogtoo, Delgerbat Boldbaatar, Esugen D. Dashdorj, Namuun E. Clifford, Arghun N. Dashdorj, Bo-Ram Bang, Takeshi Chida, Carolina Lim, Masaya Sugiyama, Masashi Mizokami, Naranjargal J. Dashdorj, Ping Liu, Jeffrey S. Glenn, Naranbaatar D. Dashdorj, Takeshi Saito. High Prevalence of Chronic Viral Hepatitis and Liver Fibrosis Among Mongols in Southern CaliforniaDigestive Diseases and Sciences 2021; 66(8): 2833 doi: 10.1007/s10620-020-06499-6
50
Arnolfo Petruzziello, Giovanna Loquercio, Rocco Sabatino, Daniel Vasile Balaban, Najeeb Ullah Khan, Mauro Piccirillo, Luis Rodrigo, Lucia di Capua, Annunziata Guzzo, Francesco Labonia, Gerardo Botti. Prevalence of Hepatitis C virus genotypes in nine selected European countries: A systematic reviewJournal of Clinical Laboratory Analysis 2019; 33(5) doi: 10.1002/jcla.22876
51
Yao Wang, Zeyu Zhao, Hao Zhang, Qin Lin, Ning Wang, Mikah Ngwanguong Hannah, Jia Rui, Tianlong Yang, Peihua Li, Siying Mao, Shengnan Lin, Xingchun Liu, Yuanzhao Zhu, Jingwen Xu, Meng Yang, Li Luo, Chan Liu, Zhuoyang Li, Bin Deng, Jiefeng Huang, Weikang Liu, Benhua Zhao, Yanhua Su, Tianmu Chen. Estimating the transmissibility of hepatitis C: A modelling study in Yichang City, ChinaJournal of Viral Hepatitis 2021; 28(10): 1464 doi: 10.1111/jvh.13582
52
Sirio Fiorino, Fabio Tateo, Dario De Biase, Claudio G Gallo, Paolo E Orlandi, Ivan Corazza, Roberta Budriesi, Matteo Micucci, Michela Visani, Elisabetta Loggi, Wandong Hong, Roberta Pica, Federico Lari, Maddalena Zippi. SARS-CoV-2: lessons from both the history of medicine and from the biological behavior of other well-known virusesFuture Microbiology 2021; 16(14): 1105 doi: 10.2217/fmb-2021-0064
53
Aaditya Chandrasekar, Brynn Chavira, Varun Kesar, Thomas Joseph, Marrieth Rubio, Anita Kablinger. Hepatitis C screening, education, and linkage to care in an acute adult inpatient psychiatric unitGeneral Hospital Psychiatry 2020; 67: 165 doi: 10.1016/j.genhosppsych.2020.06.004
54
Momen Askoura, Hisham A. Abbas, Hadeel Al Sadoun, Wesam H. Abdulaal, Amr S. Abu Lila, Khaled Almansour, Farhan Alshammari, El-Sayed Khafagy, Tarek S. Ibrahim, Wael A. H. Hegazy. Elevated Levels of IL-33, IL-17 and IL-25 Indicate the Progression from Chronicity to Hepatocellular Carcinoma in Hepatitis C Virus PatientsPathogens 2022; 11(1): 57 doi: 10.3390/pathogens11010057
55
Pramod B. Mahajan. Recent Advances in Application of Pharmacogenomics for BiotherapeuticsThe AAPS Journal 2016; 18(3): 605 doi: 10.1208/s12248-016-9903-4
56
Ruixue Wang, Saori Suzuki, Johnathan D. Guest, Brigitte Heller, Maricar Almeda, Alexander K. Andrianov, Alexander Marin, Roy A. Mariuzza, Zhen-Yong Keck, Steven K. H. Foung, Abdul S. Yunus, Brian G. Pierce, Eric A. Toth, Alexander Ploss, Thomas R. Fuerst. Induction of broadly neutralizing antibodies using a secreted form of the hepatitis C virus E1E2 heterodimer as a vaccine candidateProceedings of the National Academy of Sciences 2022; 119(11) doi: 10.1073/pnas.2112008119
57
Trudy M. Wassenaar, Se‐Ran Jun, Michael Robeson, David W. Ussery. Comparative genomics of hepatitis A virus, hepatitis C virus, and hepatitis E virus provides insights into the evolutionary history of Hepatovirus speciesMicrobiologyOpen 2020; 9(2) doi: 10.1002/mbo3.973
58
Vladimir Kartashev, Matthias Döring, Leonardo Nieto, Eleda Coletta, Rolf Kaiser, Saleta Sierra, A. Guerrero, H. Stoiber, C. Paar, A.M. Vandamme, F. Nevens, M. Van Ranst, L. Cuypers, P. Braun, R. Ehret, M. Obermeier, S. Schneeweiss, S. Scholten, K. Römer, K. Isernhagen, N. Qurashi, E. Heger, E. Knops, M. Neumann-Fraune, J. Timm, A. Walker, N. Lübke, H. Wedemeyer, J. Schulze zur Wiesch, M. Lütgehetmann, S. Polywka, M. Däumer, D. Hoffmann, U. Protzer, N. Marascio, A. Foca, M.C. Liberto, G.S. Barreca, L. Galati, C. Torti, V. Pisani, C.F. Perno, F. Ceccherini-Silberstein, V. Cento, M. Ciotti, M. Zazzi, B. Rossetti, A.De Luca, C. Caudai, O. Mor, C. Devaux, T. Staub, F. Araujo, P. Gomes, J. Cabanas, N. Markin, I. Khomenko, M. Govorukhina, G. Lugovskaya, D. Dontsov, A. Mas, E. Martró, V. Saludes, F. Rodríguez-Frías, F. García, P. Casas, A. de la Iglesia, J.C. Alados, M.J. Pena-López, M.J. Rodríguez, J.C. Galán, A. Suárez, L. Cardeñoso, M.D. Guerrero, C. Vegas-Dominguez, J. Blas-Espada, R. García, S. García-Bujalance, L. Benítez-Gutiérrez, C. de Mendoza, N. Montiel, J. Santos, I. Viciana, A. Delgado, P.A. Martínez-Sanchez, M. Fernández-Alonso, G. Reina, M. Trigo, M.J. Echeverría, A. Aguilera, D. Navarro, S. Bernal, M.C. Lozano, F. Fernández-Cuenca, A. Orduña, J.M. Eiros, R. Ortíz de Lejarazu, A.M. Martínez-Sapiña, A. García-Díaz, T. Haque. New findings in HCV genotype distribution in selected West European, Russian and Israeli regionsJournal of Clinical Virology 2016; 81: 82 doi: 10.1016/j.jcv.2016.05.010
59
Martina Smolić, Tea Omanović, Ivana Božić, Ines Bilić-Ćurčić, Robert Smolić, Aleksandar Včev. Update on Hepatitis C2017;  doi: 10.5772/intechopen.70794
60
Virginia Sedeño-Monge, Saul Laguna-Meraz, Gerardo Santos-López, Arturo Panduro, Francisca Sosa-Jurado, Alexis Jose-Abrego, Daniel Meléndez-Mena, Marco A. Muñoz-Ramírez, Monserrat Cosme-Chávez, Sonia Roman. A comprehensive update of the status of hepatitis C virus (HCV) infection in Mexico—A systematic review and meta-analysis (2008–2019)Annals of Hepatology 2021; 20: 100292 doi: 10.1016/j.aohep.2020.100292
61
Hui-Chun Li, Chee-Hing Yang, Shih-Yen Lo. Cellular factors involved in the hepatitis C virus life cycleWorld Journal of Gastroenterology 2021; 27(28): 4555-4581 doi: 10.3748/wjg.v27.i28.4555
62
Raoul Blindenbacher, Bettina Maeschli, Philip Bruggmann. The Swiss Hepatitis Strategy as a model for facing future health policy challengesHealth Policy 2019; 123(7): 681 doi: 10.1016/j.healthpol.2019.05.010
63
Hsu-Heng Yen, Pei-Yuan Su, I-Ling Liu, Ya-Yuei Zeng, Siou-Ping Huang, Yu-Chun Hsu, Chia-Wei Yang, Yang-Yuan Chen. Direct-acting antiviral treatment for Hepatitis C Virus in geriatric patients: a real-world retrospective comparison between early and late elderly patientsPeerJ 2021; 9: e10944 doi: 10.7717/peerj.10944
64
Sara Abouelasrar Salama, Mieke Gouwy, Alexandra De Zutter, Noëmie Pörtner, Lotte Vanbrabant, Nele Berghmans, Mieke De Buck, Sofie Struyf, Jo Van Damme. Induction of Chemokines by Hepatitis C Virus Proteins: Synergy of the Core Protein with Interleukin-1β and Interferon-γ in Liver Bystander CellsJournal of Interferon & Cytokine Research 2020; 40(4): 195 doi: 10.1089/jir.2019.0115
65
Daniel Ferguson, Jun Zhang, Matthew A. Davis, Robert N. Helsley, Lise-Lotte Vedin, Richard G. Lee, Rosanne M. Crooke, Mark J. Graham, Daniela S. Allende, Paolo Parini, J.Mark Brown. The lipid droplet-associated protein perilipin 3 facilitates hepatitis C virus-driven hepatic steatosisJournal of Lipid Research 2017; 58(2): 420 doi: 10.1194/jlr.M073734
66
Amjad Khan, Abdul Nadir, Muhammad Hassan Mushtaq, Khunsa Junaid, Aabish Mehreen Khan, Hassan Ali, Fatmee Waqar, Taimoor Akram Khan, Ali Akram Khan. Molecular epidemiology and genotype distribution of hepatitis C in Pakistan; a multicenter cross-sectional studyInfection, Genetics and Evolution 2020; 84: 104372 doi: 10.1016/j.meegid.2020.104372
67
Iryna V. Balaniuk, Elena V. Myronyk, Yuriy O. Randiuk, Аndriy V. Andruschak. GENERAL IMMUNOLOGICAL REACTIVITY OF PATIENT’S ORGANISM WITH CHRONIC HEPATITIS СWiadomości Lekarskie 2019; 72(7): 1310 doi: 10.36740/WLek201907115
68
Leena Chularojanamontri, Supot Nimanong, Chanisada Wongpraparut, Narumol Silpa-Archa, Chayada Chaiyabutr, Norramon Charoenpipatsin. How do we treat psoriasis patients with hepatitis C infections in real-world situations? A retrospective analysis of 34 patientsJournal of Dermatological Treatment 2021; 32(3): 321 doi: 10.1080/09546634.2019.1657225
69
KavitaN Thakur, Nirankush Borah, Shweta Gangurde, Hetal Rathod. Mutation in RNA viruses: A challenge to effective vaccine developmentMedical Journal of Dr. D.Y. Patil Vidyapeeth 2023; 16(7): 170 doi: 10.4103/mjdrdypu.mjdrdypu_315_22
70
Navroop Nagra, Richard A. Kozarek, Blaire E. Burman. Therapeutic Advances in Viral Hepatitis A–EAdvances in Therapy 2022; 39(4): 1524 doi: 10.1007/s12325-022-02070-z
71
Tamer A. Hafez. Hepatitis C in Developing Countries2018; : 25 doi: 10.1016/B978-0-12-803233-6.00003-5
72
Khayriyyah Mohd Hanafiah, Mary L. Garcia, Nadine C. Barnes, David A. Anderson. Detection of virus-specific polymeric immunoglobulin A in acute hepatitis A, C, E virus serum samples using novel chimeric secretory componentBMC Research Notes 2018; 11(1) doi: 10.1186/s13104-018-3799-2
73
Isabela S. Oliveira, Lucas P. Carvalho, Maria Isabel Schinoni, Raymundo Paraná, Ajax M. Atta, Maria Luiza B. Sousa Atta. Peripheral lymphocyte subsets in chronic hepatitis C: Effects of 12 weeks of antiviral treatment with interferon-alpha plus ribavirinMicrobial Pathogenesis 2016; 91: 155 doi: 10.1016/j.micpath.2015.12.007
74
Winifred Nyinoh Iveren. Genotypic variation, demographic characteristics and risk factors of hepatitis C virus in ScotlandJournal of Public Health and Epidemiology 2018; 10(7): 241 doi: 10.5897/JPHE2018.1031
75
Patrick R. Brown, Omar Sadiq, Alexander Weick, Adrienne Lenhart, Mohammad Elbatta, Christopher Fernandez, Anas Kutait, Robert Pompa, Syed‐Mohammed Jafri. Acute Kidney Injury in Patients Undergoing Chronic Hepatitis C Virus Treatment With Ledipasvir/SofosbuvirHepatology Communications 2018; 2(10): 1172 doi: 10.1002/hep4.1243
76
F. De Conto, M. C. Medici, F. Ferraglia, F. Pinardi, A. Fazzi, M. C. Arcangeletti, C. Chezzi, A. Calderaro. Temporal dynamics of hepatitis C genotypes in a five-year hospital-based surveillance in Northern ItalyArchives of Virology 2016; 161(10): 2727 doi: 10.1007/s00705-016-2975-8
77
Gary Brook, Sanjay Bhagani, Ranjababu Kulasegaram, Adele Torkington, David Mutimer, Elizabeth Hodges, Louise Hesketh, Simon Farnworth, Verity Sullivan, Charles Gore, Emma Devitt, Ann K Sullivan. United Kingdom National Guideline on the Management of the viral hepatitides A, B and C 2015International Journal of STD & AIDS 2016; 27(7): 501 doi: 10.1177/0956462415624250
78
Kittiyod Poovorawan, Wirichada Pan-ngum, Lisa J. White, Ngamphol Soonthornworasiri, Polrat Wilairatana, Rujipat Wasitthankasem, Pisit Tangkijvanich, Yong Poovorawan, Jason Grebely. Estimating the Impact of Expanding Treatment Coverage and Allocation Strategies for Chronic Hepatitis C in a Direct Antiviral Agent EraPLOS ONE 2016; 11(9): e0163095 doi: 10.1371/journal.pone.0163095
79
Marcos Galasso, Jordan J. Feld, Yui Watanabe, Mauricio Pipkin, Cara Summers, Aadil Ali, Robert Qaqish, Manyin Chen, Rafaela V. P. Ribeiro, Khaled Ramadan, Layla Pires, Vanderlei S. Bagnato, Cristina Kurachi, Vera Cherepanov, Gray Moonen, Anajara Gazzalle, Thomas K. Waddell, Mingyao Liu, Shaf Keshavjee, Brian C. Wilson, Atul Humar, Marcelo Cypel. Inactivating hepatitis C virus in donor lungs using light therapies during normothermic ex vivo lung perfusionNature Communications 2019; 10(1) doi: 10.1038/s41467-018-08261-z
80
Francesco Caso, Luca Cantarini, Filomena Morisco, Antonio Del Puente, Roberta Ramonda, Ugo Fiocco, Ennio Lubrano, Rosario Peluso, Paolo Caso, Mauro Galeazzi, Leonardo Punzi, Raffaele Scarpa, Luisa Costa. Current evidence in the field of the management with TNF-α inhibitors in psoriatic arthritis and concomitant hepatitis C virus infectionExpert Opinion on Biological Therapy 2015; 15(5): 641 doi: 10.1517/14712598.2015.1011616
81
Gary Brook, Norbert Brockmeyer, Thijs van de Laar, Sven Schellberg, Andrew J Winter. 2017 European guideline for the screening, prevention and initial management of hepatitis B and C infections in sexual health settingsInternational Journal of STD & AIDS 2018; 29(10): 949 doi: 10.1177/0956462418767576
82
Santiago Sánchez-Pardo, Andrés Ochoa-Díaz, Jhon E Prieto-Ortiz. Alteraciones Hepaticas en pacientes con infección por VIH en un centro de investigacion en Bogotá Colombia 2009 – 2019Infectio 2021; 25(4): 250 doi: 10.22354/in.v25i4.956
83
Beatriz Torres-Vázquez, Ana María de Lucas, Carlos García-Crespo, Juan Antonio García-Martín, Adrián Fragoso, María Fernández-Algar, Celia Perales, Esteban Domingo, Miguel Moreno, Carlos Briones. In vitro Selection of High Affinity DNA and RNA Aptamers that Detect Hepatitis C Virus Core Protein of Genotypes 1 to 4 and Inhibit Virus Production in Cell CultureJournal of Molecular Biology 2022; 434(7): 167501 doi: 10.1016/j.jmb.2022.167501
84
Ronaldo Luis Thomasini, Hortencia Gisele Amaro Souza, Oscar Bruna‐Romero, Antonio Helvecio Totola, Neiva Sellan Lopes Gonçales, Cristiano Xavier Lima, Mauro Martins Teixeira. Evaluation of a recombinant multiepitope antigen for diagnosis of hepatitis C virus: A lower cost alternative for antigen productionJournal of Clinical Laboratory Analysis 2018; 32(6) doi: 10.1002/jcla.22410
85
Jeffrey V. Lazarus, Elena Roel, Ahmed M. Elsharkawy. Hepatitis C Virus Epidemiology and the Impact of Interferon-Free Hepatitis C Virus TherapyCold Spring Harbor Perspectives in Medicine 2020; 10(3): a036913 doi: 10.1101/cshperspect.a036913
86
Hilla Knobler, Stephen Malnick. Hepatitis C and insulin action: An intimate relationshipWorld Journal of Hepatology 2016; 8(2): 131-138 doi: 10.4254/wjh.v8.i2.131
87
Rodolfo Castro, Hugo Perazzo, Beatriz Grinsztejn, Valdilea G. Veloso, Chris Hyde. Chronic Hepatitis C: An Overview of Evidence on Epidemiology and Management from a Brazilian PerspectiveInternational Journal of Hepatology 2015; 2015: 1 doi: 10.1155/2015/852968
88
Quratulain Maqsood, Maria Hussain, Aleena Sumrin. Hepatitis C - Recent Advances2023;  doi: 10.5772/intechopen.1001050
89
Sara Abouelasrar Salama, Muriel Lavie, Mieke De Buck, Jo Van Damme, Sofie Struyf. Cytokines and serum amyloid A in the pathogenesis of hepatitis C virus infectionCytokine & Growth Factor Reviews 2019; 50: 29 doi: 10.1016/j.cytogfr.2019.10.006
90
G.S. Pancar, T. Kaynar. Nailfold capillaroscopic changes in patients with chronic viral hepatitisMicrovascular Research 2020; 129: 103970 doi: 10.1016/j.mvr.2019.103970
91
Justin Chu. Assisted Reproduction Techniques2021; : 26 doi: 10.1002/9781119622215.ch5
92
Vigneswaran Narayanamurthy, Z. E. Jeroish, K. S. Bhuvaneshwari, Fahmi Samsuri. Hepatitis C virus (HCV) diagnosis via microfluidicsAnalytical Methods 2021; 13(6): 740 doi: 10.1039/D0AY02045A
93
Hugo Ramón Rosen. “Hep C, where art thou”: What are the remaining (fundable) questions in hepatitis C virus research?Hepatology 2017; 65(1): 341 doi: 10.1002/hep.28848
94
A.A. Khryanin, A.V. Sokolovskaia, V.K. Bocharova. Lichen planus associated with viral hepatitis C: new data, concepts and hypothesesKlinicheskaya dermatologiya i venerologiya 2023; 22(4): 426 doi: 10.17116/klinderma202322041426
95
A. Ferreira-Gonzalez. Diagnostic Molecular Pathology2017; : 485 doi: 10.1016/B978-0-12-800886-7.00038-8
96
Valeriu Harabor, Raluca Mogos, Aurel Nechita, Ana-Maria Adam, Gigi Adam, Alina-Sinziana Melinte-Popescu, Marian Melinte-Popescu, Mariana Stuparu-Cretu, Ingrid-Andrada Vasilache, Elena Mihalceanu, Alexandru Carauleanu, Anca Bivoleanu, Anamaria Harabor. Machine Learning Approaches for the Prediction of Hepatitis B and C SeropositivityInternational Journal of Environmental Research and Public Health 2023; 20(3): 2380 doi: 10.3390/ijerph20032380
97
Victoria Belousova, Ahmed A. Abd-Rabou, Shaker A. Mousa. Recent advances and future directions in the management of hepatitis C infectionsPharmacology & Therapeutics 2015; 145: 92 doi: 10.1016/j.pharmthera.2014.09.002
98
Guglielmo Borgia, Riccardo Scotto, Antonio Riccardo Buonomo. An update on recent developments in the search for hepatitis C virus therapies with pan-genotypic efficacyExpert Opinion on Investigational Drugs 2019; 28(5): 395 doi: 10.1080/13543784.2019.1602766
99
Nadia A. Nabulsi, Michelle T. Martin, Lisa K. Sharp, David E. Koren, Robyn Teply, Autumn Zuckerman, Todd A. Lee. Predicting Treatment Failure for Initiators of Hepatitis C Virus Treatment in the era of Direct-Acting Antiviral TherapyFrontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.551500
100
Ս․Ռ․ Սարգսյան. ՔՐՈՆԻԿ ՎԻՐՈՒՍԱՅԻՆ C ՀԵՊԱՏԻՏ. ՀԱԿԱՎԻՐՈՒՍԱՅԻՆ ԲՈՒԺՄԱՆ ՓՈՒԼԵՐԸ (ՎԵՐԼՈՒԾՈՒԹՅՈՒՆ)MEDICINE, SCIENCE AND EDUCATION 2022; (33): 22 doi: 10.56936/18291775-2022.33-22
101
Manish Dwivedi, Aditya Dwivedi, Debalina Mukherjee. An Insight into Hepatitis C Virus: In Search of Promising Drug TargetsCurrent Drug Targets 2023; 24(14): 1127 doi: 10.2174/0113894501265769231020031857
102
Daire O'Shea, John Law, Adrian Egli, Donna Douglas, Gary Lund, Sarah Forester, Joshua Lambert, Mansun Law, Dennis R. Burton, D. L. J. Tyrrell, Michael Houghton, Atul Humar, Norman Kneteman. Prevention of hepatitis C virus infection using a broad cross‐neutralizing monoclonal antibody (AR4A) and epigallocatechin gallateLiver Transplantation 2016; 22(3): 324 doi: 10.1002/lt.24344
103
A. Aguilera, D. Navarro, F. Rodríguez‐Frias, I. Viciana, A. M. Martínez‐Sapiña, M. J. Rodríguez, E. Martró, M. C. Lozano, E. Coletta, L. Cardeñoso, A. Suárez, M. Trigo, J. Rodríguez‐Granjer, N. Montiel, A. de la Iglesia, J. C. Alados, C. Vegas, S. Bernal, F. Fernández‐Cuenca, M. J. Pena, G. Reina, S. García‐Bujalance, M. J. Echevarria, L. Benítez, S. Pérez‐Castro, D. Ocete, I. García‐Arata, C. Guerrero, M. Rodríguez‐Iglesias, P. Casas, F. García. Prevalence and distribution of hepatitis C virus genotypes in Spain during the 2000‐2015 period (the GEHEP 005 study)Journal of Viral Hepatitis 2017; 24(9): 725 doi: 10.1111/jvh.12700
104
Jing Peng, Yanjun Lu, Weiyong Liu, Yaowu Zhu, Xiaoling Yan, Jingxin Xu, Xiong Wang, Yue Wang, Wei Liu, Ziyong Sun, Yury E Khudyakov. Genotype Distribution and Molecular Epidemiology of Hepatitis C Virus in Hubei, Central ChinaPLOS ONE 2015; 10(9): e0137059 doi: 10.1371/journal.pone.0137059
105
Petra Surlin, Dorin Nicolae Gheorghe, Liliana Foia, Amelia Surdu, Vasilica Toma, Sorina Mihaela Solomon, Dan Nicolae Florescu, Ion Rogoveanu. Hepatitis C - From Infection to Cure2018;  doi: 10.5772/intechopen.76135
106
Basim M. Ali, Furqan Moein, Maha Al-Andaleb, Shaymaa Dhyaa. A field study dealing with biocmetrics of some clinical variables for hepatitis C patientsAl-Kufa University Journal for Biology 2021; 13(2): 32 doi: 10.36320/ajb/v13.i2.11757
107
Arnolfo Petruzziello, Samantha Marigliano, Giovanna Loquercio, Carmela Cacciapuoti. Hepatitis C virus (HCV) genotypes distribution: an epidemiological up-date in EuropeInfectious Agents and Cancer 2016; 11(1) doi: 10.1186/s13027-016-0099-0
108
Ning Zhao, Wei Zheng, Dan Wu, Xuelian Wang, Wei Yang, Lin Yuan, Zhiqiang Niu, Xiaodi Jiang, Fen Huang, Zhiwei Li. Clinical value of hepatitis C virus core antigen levels in monitoring acute hepatitis C spontaneous clearance or treatment‐induced clearanceJournal of Medical Virology 2018; 90(12): 1787 doi: 10.1002/jmv.25256
109
Alexios Chatzigoulas, Zoe Cournia. Rational design of allosteric modulators: Challenges and successesWIREs Computational Molecular Science 2021; 11(6) doi: 10.1002/wcms.1529
110
Harita Nyalakonda, Netanya S. Utay. A new era of therapy for hepatitis C virus infectionCurrent Opinion in Infectious Diseases 2015; 28(5): 471 doi: 10.1097/QCO.0000000000000190
111
Yutaka Kawano, Koji Miyanishi, Satoshi Takahashi, Tomohiro Kubo, Kazuma Ishikawa, Shintaro Sugita, Kohichi Takada, Masayoshi Kobune, Tadashi Hasegawa, Junji Kato. Hepatitis C virus reactivation due to antiemetic steroid therapy during treatment of hepatocellular carcinomaJournal of Infection and Chemotherapy 2017; 23(5): 323 doi: 10.1016/j.jiac.2016.12.008
112
Yanli Bai, Yanrong Zhou, Huabing Liu, Liurong Fang, Jiangong Liang, Shaobo Xiao. Glutathione-Stabilized Fluorescent Gold Nanoclusters Vary in Their Influences on the Proliferation of Pseudorabies Virus and Porcine Reproductive and Respiratory Syndrome VirusACS Applied Nano Materials 2018; 1(2): 969 doi: 10.1021/acsanm.7b00386
113
Vijay Gayam, Arshpal Gill, Pavani Garlapati, Smruti Mohanty. Hepatitis B and C2020;  doi: 10.5772/intechopen.83609
114
Ruirui Chang, Si-Tao Xu, Hao-Wen Jin, Yong-Jie Zhao, Tian-Yu Hu, Guangji Wang, Jiankun Wang, Le Zhen. Simultaneous determination of ZL-01, a novel nucleotide prodrug, and its metabolites in rat plasma by LC-MS/MS: Application to pharmacokinetic studyJournal of Pharmaceutical and Biomedical Analysis 2022; 208: 114437 doi: 10.1016/j.jpba.2021.114437
115
Mathilde Bourdon, Alicia Garnier, Chloé Maignien, Louis Marcellin, Emmanuel Dulioust, Philippe Sogni, Odile Launay, Khaled Pocate Cheriet, Catherine Patrat, Charles Chapron, Pietro Santulli. Assisted reproductive technology outcomes in women with a chronic viral diseaseAIDS 2021; 35(7): 1073 doi: 10.1097/QAD.0000000000002859
116
Bianca Heinrich, John P. Bilello. Antimicrobial Drug Resistance2017; : 579 doi: 10.1007/978-3-319-46718-4_39
117
Abolghasem Asadi-Saghandi, Ali Shams, Gilda Eslami, Seyed Ali Mirghanizadeh, Ebrahim Eskandari-Nasab. Peginterferon Alfa-2a/Ribavirin treatment efficacy in chronic hepatitis C patients is related to natural killer group 2D gene rs1049174 GC polymorphismVirusDisease 2016; 27(4): 369 doi: 10.1007/s13337-016-0349-1